Article
Autophagy inhibition impairs leukemia stem cell function in FLT3-ITD AML but has antagonistic interactions with tyrosine kinase inhibition.
Leukemia - 1 Nov 2022
Qiu Shaowei, Kumar Harish, Yan Chengcheng, Li Hui, Paterson Andrew J, Anderson Nicholas R, He Jianbo, Yang Jing, Xie Min, Crossman David K, Lu Rui, Welner Robert S, Bhatia Ravi
Abstract excerpt
The FLT3-ITD mutation is associated with poor prognosis in acute myeloid leukemia (AML). FLT3 tyrosine kinase inhibitors (TKIs) demonstrate clinical efficacy but fail to target leukemia stem cells (LSC) and do not generate sustained responses. Autophagy is an important cellular stress response contributing to hematopoietic stem cells (HSC) maintenance and promoting leukemia development. Here we investigated the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
